CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-21 | Lecault Veronique Chief Operating Officer | Option exercise | +83,334 | $0.19 | $16K | 2,123,456 |
| 2024-06-21 | Lecault Veronique Chief Operating Officer | Option exercise · Share option (right to buy) | −83,334 | 3,829,771 | ||
| 2024-06-21 | Hayden Michael R Director | Grant or award · Share option (right to buy) | +163,934 | 660,979 | ||
| 2024-06-21 | Lo Andrew Director | Grant or award · Share option (right to buy) | +163,934 | 302,490 | ||
| 2024-06-21 | Montalbano John S. Director | Grant or award · Share option (right to buy) | +163,934 | 790,979 | ||
| 2024-05-31 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 785,750 |
| 2024-05-31 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 8,372,473 | ||
| 2024-02-26 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 729,625 |
| 2024-02-26 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 8,428,598 | ||
| 2024-01-14 | Lecault Veronique Chief Operating Officer | Grant or award · Share option (right to buy) | +770,416 | 3,913,105 | ||
| 2024-01-14 | Stimart Tryn Chief Legal Officer | Grant or award · Share option (right to buy) | +616,333 | 3,274,714 | ||
| 2024-01-14 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +770,416 | 6,590,897 | ||
| 2024-01-14 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,095,532 | 8,484,723 | ||
| 2023-12-19 | Thermopylae Holdings Ltd. 10% owner | Gift | −210,000 | 55,802,493 | ||
| 2023-11-23 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 673,500 |
| 2023-11-23 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 6,389,191 | ||
| 2023-11-08 | Montalbano John S. Director | Purchase | +10,000 | $4.46 | $45K | 86,000 |
| 2023-11-06 | Montalbano John S. Director | Purchase | +20,000 | $4.64 | $93K | 76,000 |
| 2023-09-22 | Hayden Michael R Director | Purchase | +20,000 | $4.91 | $98K | 1,323,397 |
| 2023-09-12 | Lecault Veronique Chief Operating Officer | Purchase | +20,000 | $5.19 | $104K | 2,040,122 |
Page 3 of 11 · 203 trades